Artificial intelligence (AI) software developer Imbio has signed a deal with U.K. cardiothoracic radiology services provider Heart&Lung Health.
In a statement from Imbio, Heart&Lung Health said it would use Imbio's AI quantitative imaging algorithms in routine practice to augment reporting of CT thorax studies in patients with potential lung diseases. Specifically, the software will be utilized to identify lung and cardiac conditions, according to Imbio.
